Marvin White - EMERGENT BIOSOLUT Director

ER4 Stock  EUR 5.25  0.08  1.50%   

Insider

Marvin White is Director of EMERGENT BIOSOLUT since 2020.
Age 53
Tenure 5 years

Marvin White Latest Insider Activity

Tracking and analyzing the buying and selling activities of Marvin White against EMERGENT BIOSOLUT stock is an integral part of due diligence when investing in EMERGENT BIOSOLUT. Marvin White insider activity provides valuable insight into whether EMERGENT BIOSOLUT is net buyers or sellers over its current business cycle. Note, EMERGENT BIOSOLUT insiders must abide by specific rules, including filing SEC forms every time they buy or sell EMERGENT BIOSOLUT'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Similar Executives

Found 11 records

INSIDER Age

Yue XinCITIC Telecom International
75
Hon IpCITIC Telecom International
52
Frank IpCITIC Telecom International
N/A
Dawei CaiCITIC Telecom International
45
Mun TsoCITIC Telecom International
61
Fuk PoonCITIC Telecom International
57
FCIS FCSCOFCO Joycome Foods
47
Nan ZhangCOFCO Joycome Foods
42
Zhenjun LuanCITIC Telecom International
56
Yuet CheungCITIC Telecom International
50
Kee YuenCITIC Telecom International
74
EMERGENT BIOSOLUT (ER4) is traded on Berlin Exchange in Germany and employs 18 people.

EMERGENT BIOSOLUT Leadership Team

Elected by the shareholders, the EMERGENT BIOSOLUT's board of directors comprises two types of representatives: EMERGENT BIOSOLUT inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EMERGENT. The board's role is to monitor EMERGENT BIOSOLUT's management team and ensure that shareholders' interests are well served. EMERGENT BIOSOLUT's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EMERGENT BIOSOLUT's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert Kramer, CFO, Interim Executive Vice President - Corporate Services Division, Principal Financial and Accounting Officer, Treasurer
Sean Kirk, Executive Vice President Manufacturing and Technical Operations
Katherine Strei, Executive Vice President, Human Resources and Communications, Chief Human Resources Officer
Fuad ElHibri, Executive Chairman of the Board
Sue Bailey, Independent Director
Jerome Hauer, Independent Director
Marvin White, Director
Kathryn Zoon, Independent Director
Atul Saran, Executive Vice President Corporate Development, General Counsel and Corporate Secretary
Seamus Mulligan, Director
George Joulwan, Independent Director
Adam Havey, Executive Vice President and Presidentident - BioDefense Division
Louis Sullivan, Independent Director
Ronald Richard, Lead Independent Director
Zsolt Harsanyi, Independent Director
Richard Lindahl, Chief Financial Officer, Executive Vice President, Treasurer

EMERGENT Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EMERGENT BIOSOLUT a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in EMERGENT Stock

EMERGENT BIOSOLUT financial ratios help investors to determine whether EMERGENT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EMERGENT with respect to the benefits of owning EMERGENT BIOSOLUT security.